Related Experiment Video
Updated: Aug 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic Architecture of Pediatric Cardiomyopathies Assessed by Whole-Exome Sequencing: Insights Into Early-Onset and
Luana Giovannangeli1, Elise Daire2,3, Kahia Messaoudi1,3
1Laboratoire de Génétique Constitutionnelle, CHU Amiens-Picardie, Amiens, France.
Insights
Whole-exome sequencing (WES) is effective for diagnosing pediatric cardiomyopathies (CM), identifying genetic variants in over 60% of cases. Early diagnosis and syndromic genes are crucial for understanding severe pediatric heart conditions.
Area of Science:
- Pediatric Cardiology
- Genetics
- Molecular Biology
Background:
- Pediatric cardiomyopathies (CM) are rare, heterogeneous heart muscle disorders in children.
- Genetic basis of adult CM is known, but less defined in pediatric forms, especially early-onset and syndromic cases.
Purpose of the Study:
- To characterize the genetic architecture of pediatric cardiomyopathies (CM).
- To evaluate the utility of Whole-Exome Sequencing (WES) in diagnosing pediatric CM.
Main Methods:
- Retrospective study of 59 pediatric patients with CM from 2018-2024.
- Whole-Exome Sequencing (WES) was performed to identify genetic variants.
Main Results:
- WES identified at least one Variant Of Interest (VOI) in 62.7% of patients.
- Pathogenic/Likely Pathogenic (P/LP) variants were found in 45.8% of cases; 16.9% were Variants of Uncertain Significance (VUS).
- Higher diagnostic yield for hypertrophic CM (HCM) (67.7%) and dilated CM (DCM) (57.1%), particularly in infants diagnosed before 1 year (72.7%).
- Significant proportion (55%) of patients diagnosed before 6 months had variants in syndromic genes, even with initially isolated cardiac phenotypes.
Conclusions:
- WES is a valuable first-line diagnostic tool for pediatric CM.
- Complex and syndromic genetic factors significantly contribute to early-onset and severe pediatric cardiomyopathies.
Abstract:
Pediatric cardiomyopathies (CM) are rare and heterogeneous heart disorders, including hypertrophic, dilated, restrictive, arrhythmogenic, and non-dilated CM. While their genetic basis is well characterized in adults, it remains less clearly defined in children particularly in early-onset apparently isolated and syndromic forms. We conducted a retrospective study (2018-2024) of 59 pediatric patients who underwent Whole-Exome Sequencing (WES) for CM at Amiens and Lille University Hospitals, aiming to characterize the genetic architecture of pediatric CM. WES identified at least one Variant Of Interest (VOI) in 62.7% of patients (37/59), including 45.8% (27/59) of P/LP variants, and 16.9% (10/59) of VUS. VOI identification yields for HCM and DCM were respectively 67.7% and 57.1%. Yield was higher in patients diagnosed before 1 year of age compared with those diagnosed later (72.7% vs. 56.7%). Variants were identified in classical CM genes, including sarcomeric genes, but also in less typical and syndromic genes. Among patients diagnosed before 6 months, 55% carried a variant in genes associated with syndromic cardiomyopathy, including cases with initially isolated cardiac phenotypes. These findings support the use of WES as a first-line approach in pediatric CM and highlight the contribution of complex and syndromic genetic architectures to early-onset and severe diseases.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
07:34Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Animal Mitochondrial Genetics